GABRIELLE CORPUZ: Open Payments
NPI 1063051019 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 62 payments from 16 companies in 2025. Trend: 2023 $943 · 2024 $1,334 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $177 |
| Madrigal Pharmaceuticals | 12 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| VIVUS LLC | 5 | $74 |
| GENZYME CORPORATION | 3 | $62 |
| Ardelyx, Inc. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| PFIZER INC. | 3 | $49 |
| Lilly USA, LLC | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $39 |
Products named: REZDIFFRA, SKYRIZI, DUPIXENT, ENTYVIO, CREON, IBSRELA, XIFAXAN, XELJANZ.
Industry payments across NJ — which companies pay providers there.
